BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Company Description Revnuu is a marketing and commercialization partner for deep-tech and life sciences companies, helping transform complex innovations into category-leading brands. The team enables technical founders to focus on R&D while Revnuu manages the entire
Company Description Revnuu is a marketing and commercialization partner for deep-tech and life sciences companies, helping transform complex innovations into category-leading brands. The team enables technical founders to focus on R&D while Revnuu manages the entire
Basel Area Business & Innovation is the economic promotion agency for the Basel Area and the strategic growth partner helping scalable ventures in science and tech to land, launch and level up in the Basel Area
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)